Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$516M Hold
4,842,880
4.41% 6
2026
Q1
$792M Buy
4,842,880
+1
+0% +$154 7.88% 2
2025
Q4
$843M Buy
4,842,879
+1,758,321
+57% +$321M 8.44% 2
2025
Q3
$444M Hold
3,084,558
5.47% 5
2025
Q2
$310M Buy
3,084,558
+70,000
+2% +$5.35M 4.42% 6
2025
Q1
$230M Hold
3,014,558
3.52% 10
2024
Q4
$208M Sell
3,014,558
-257,450
-8% -$18.5M 3.15% 11
2024
Q3
$239M Sell
3,272,008
-368,100
-10% -$27.2M 3.46% 11
2024
Q2
$244M Buy
3,640,108
+1,775,000
+95% +$68.8M 3.78% 8
2024
Q1
$50.6M Hold
1,865,108
0.75% 39
2023
Q4
$57.8M Hold
1,865,108
0.9% 32
2023
Q3
$47.1M Buy
1,865,108
+865,108
+87% +$19.8M 0.99% 26
2023
Q2
$21.1M Buy
+1,000,000
New +$19M 0.4% 36

Other funds holding INSM

RTW Investments's INSM Position: Q2 2026 in Review

RTW Investments held its Insmed (INSM) position steady in Q2 2026 at 4,842,880 shares worth $516M. The position accounts for 4.41% of the portfolio, ranked #6.

RTW Investments first reported a position in INSM in Q2 2023 and has held it in 13 quarters since. The position peaked at $843M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • RTW Investments held 4,842,880 shares of Insmed worth $516M as of Q2 2026.
  • RTW Investments left its Insmed share count unchanged in Q2 2026.
  • Insmed made up 4.41% of RTW Investments's portfolio in Q2 2026, its #6 holding.
  • RTW Investments first reported a position in Insmed in Q2 2023 and has held it in 13 quarters since.
  • RTW Investments's Insmed position peaked at $843M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.